Bath & Body Works (NYSE:BBWI - Get Free Report) updated its FY 2026 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of 2.600-2.800 for the period, compared to the consensus earnings per share estimate of 2.560. The company issued revenue guidance of $7.0 billion-$7.1 billion, compared to the consensus revenue estimate of $7.0 billion. Bath & Body Works also updated its Q4 2026 guidance to 1.410-1.610 EPS.
Bath & Body Works Stock Performance
NYSE BBWI opened at $18.68 on Thursday. The company has a market cap of $3.77 billion, a P/E ratio of 4.86, a P/E/G ratio of 0.92 and a beta of 1.31. The business's 50 day moving average price is $19.21 and its 200-day moving average price is $19.78. Bath & Body Works has a fifty-two week low of $14.27 and a fifty-two week high of $24.94.
Bath & Body Works (NYSE:BBWI - Get Free Report) last issued its quarterly earnings results on Thursday, November 19th. The company reported $0.26 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.12 by $0.14. Bath & Body Works had a negative return on equity of 53.48% and a net margin of 10.83%. The company had revenue of $1.58 billion during the quarter, compared to the consensus estimate of $1.55 billion. Bath & Body Works has set its Q4 2026 guidance at 1.410-1.610 EPS and its FY 2026 guidance at 2.600-2.800 EPS. As a group, equities analysts predict that Bath & Body Works will post 2.74 EPS for the current year.
Bath & Body Works Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, December 4th. Stockholders of record on Friday, November 20th will be issued a $0.20 dividend. This represents a $0.80 annualized dividend and a dividend yield of 4.3%. The ex-dividend date is Friday, November 20th. Bath & Body Works's dividend payout ratio (DPR) is 20.83%.
Analyst Ratings Changes
BBWI has been the subject of a number of recent analyst reports. Jefferies Financial Group lifted their price target on shares of Bath & Body Works from $22.00 to $23.00 and gave the stock a "hold" rating in a research note on Tuesday, July 28th. Wells Fargo & Company increased their price objective on shares of Bath & Body Works from $24.00 to $25.00 and gave the stock an "overweight" rating in a research report on Thursday, October 29th. Robert W. Baird decreased their price objective on shares of Bath & Body Works from $25.00 to $23.00 and set a "neutral" rating for the company in a research note on Thursday, August 27th. JPMorgan Chase & Co. raised their price objective on shares of Bath & Body Works from $22.00 to $24.00 and gave the stock a "neutral" rating in a research note on Tuesday, August 18th. Finally, UBS Group boosted their target price on Bath & Body Works from $17.00 to $22.00 and gave the company a "neutral" rating in a research report on Friday, November 13th. Four equities research analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company currently has an average rating of "Hold" and a consensus price target of $22.53.
Get Our Latest Stock Report on Bath & Body Works
Bath & Body Works Company Profile
(
Get Free Report)
Bath & Body Works, Inc. is a specialty retailer focused on personal care and home fragrance products. Its offerings include body lotions, soaps, fragrances, hand sanitizers, candles and other home-fragrance items, sold under the Bath & Body Works and White Barn brands. The company serves customers through its stores and e-commerce platform in the United States and Canada, as well as through international franchise, license and wholesale partners. Bath & Body Works traces its roots to a store launched in 1990.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Bath & Body Works, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bath & Body Works wasn't on the list.
While Bath & Body Works currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.
Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.